Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Chou

Showing results (91-100 of 120) with videos related to

Pageof 12
Sort By:
Genome Research|September 22, 2021
A single-cell tumor immune atlas for precision oncologyPaula Nieto, Marc Elosua-Bayes, Juan L Trincado, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 3, 2021
International Medullary Thyroid Carcinoma Grading System: A Validated Grading System for Medullary Thyroid CarcinomaBin Xu, Talia L Fuchs, Sara Ahmadi, et al.
The American Journal of Surgical Pathology|July 10, 2024
Artificial Intelligence-based Segmentation of Residual Pancreatic Cancer in Resection Specimens Following Neoadjuvant Treatment (ISGPP-2): International Improvement and Validation StudyBoris V Janssen, Bart Oteman, Mahsoem Ali, et al.
The British Journal of Surgery|November 4, 2022
Histopathological tumour response scoring in resected pancreatic cancer following neoadjuvant therapy: international interobserver study (ISGPP-1)Boris V Janssen, Stijn van Roessel, Susan van Dieren, et al.
Oncogene|June 21, 2026
HSP47 is a potential dual cell target and prognostic factor in pancreatic cancerGeorge Sharbeen, Estrella Gonzales-Aloy, Janet Youkhana, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2015
Precision Medicine for Advanced Pancreas Cancer: The Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) TrialLorraine A Chantrill, Adnan M Nagrial, Clare Watson, et al.
Cancer Research Communications|September 26, 2025
Mapping the Proteomic Landscape of Pancreatic Cancer: Prognostic Insights and Subtype StratificationAdel T Aref, Jason Grealey, Mohashin Pathan, et al.
Genome Medicine|September 6, 2013
Clinical and molecular characterization of HER2 amplified-pancreatic cancerAngela Chou, Nicola Waddell, Mark J Cowley, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 3, 2020
RAF1 rearrangements are common in pancreatic acinar cell carcinomasOwen W J Prall, Violeta Nastevski, Huiling Xu, et al.
Oncotarget|September 19, 2015
Prognostic role and implications of mutation status of tumor suppressor gene ARID1A in cancer: a systematic review and meta-analysisClaudio Luchini, Nicola Veronese, Marco Solmi, et al.
Pageof 12

Showing results (91-100 of 120) with videos related to

Sort By:
Pageof 12
Genome Research|September 22, 2021
A single-cell tumor immune atlas for precision oncologyPaula Nieto, Marc Elosua-Bayes, Juan L Trincado, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 3, 2021
International Medullary Thyroid Carcinoma Grading System: A Validated Grading System for Medullary Thyroid CarcinomaBin Xu, Talia L Fuchs, Sara Ahmadi, et al.
The American Journal of Surgical Pathology|July 10, 2024
Artificial Intelligence-based Segmentation of Residual Pancreatic Cancer in Resection Specimens Following Neoadjuvant Treatment (ISGPP-2): International Improvement and Validation StudyBoris V Janssen, Bart Oteman, Mahsoem Ali, et al.
The British Journal of Surgery|November 4, 2022
Histopathological tumour response scoring in resected pancreatic cancer following neoadjuvant therapy: international interobserver study (ISGPP-1)Boris V Janssen, Stijn van Roessel, Susan van Dieren, et al.
Oncogene|June 21, 2026
HSP47 is a potential dual cell target and prognostic factor in pancreatic cancerGeorge Sharbeen, Estrella Gonzales-Aloy, Janet Youkhana, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2015
Precision Medicine for Advanced Pancreas Cancer: The Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) TrialLorraine A Chantrill, Adnan M Nagrial, Clare Watson, et al.
Cancer Research Communications|September 26, 2025
Mapping the Proteomic Landscape of Pancreatic Cancer: Prognostic Insights and Subtype StratificationAdel T Aref, Jason Grealey, Mohashin Pathan, et al.
Genome Medicine|September 6, 2013
Clinical and molecular characterization of HER2 amplified-pancreatic cancerAngela Chou, Nicola Waddell, Mark J Cowley, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 3, 2020
RAF1 rearrangements are common in pancreatic acinar cell carcinomasOwen W J Prall, Violeta Nastevski, Huiling Xu, et al.
Oncotarget|September 19, 2015
Prognostic role and implications of mutation status of tumor suppressor gene ARID1A in cancer: a systematic review and meta-analysisClaudio Luchini, Nicola Veronese, Marco Solmi, et al.
Pageof 12